Literature DB >> 23975688

Noncanonical Nuclear Factor Kappa B (NF-κB) Signaling and Potential for Therapeutics in Sepsis.

Simone Thair1, James A Russell.   

Abstract

NF-κB signaling plays a central role in the pathophysiology of severe sepsis and septic shock. Despite tremendous and missed efforts, novel therapeutics for severe sepsis and septic shock are still needed. Many drugs have been designed to target the canonical NF-κB signaling pathway with limited success, potentially due to the nonspecificity of the drugs for other kinases and the interaction of canonical signaling with other pathways. Here, we review the canonical and noncanonical signaling pathways of NF-κB, the cross talk and negative regulation of the two pathways, and the potential for therapeutics arising from the noncanonical NF-κB pathway in relation to the pathophysiology of septic shock.

Entities:  

Year:  2013        PMID: 23975688     DOI: 10.1007/s11908-013-0362-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  91 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation.

Authors:  T Huxford; D B Huang; S Malek; G Ghosh
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

4.  Structure of an IkappaBalpha/NF-kappaB complex.

Authors:  M D Jacobs; S C Harrison
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

5.  Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.

Authors:  Didier Keh; Thomas Boehnke; Steffen Weber-Cartens; Christina Schulz; Olaf Ahlers; Sven Bercker; Hans-Dieter Volk; Wolf-Dietrich Doecke; Konrad J Falke; Herwig Gerlach
Journal:  Am J Respir Crit Care Med       Date:  2002-11-08       Impact factor: 21.405

6.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation.

Authors:  Gutian Xiao; Abraham Fong; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

8.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  A20 is dynamically regulated in the heart and inhibits the hypertrophic response.

Authors:  Stuart A Cook; Mikhail S Novikov; Youngkeun Ahn; Takashi Matsui; Anthony Rosenzweig
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

View more
  4 in total

1.  Honokiol Attenuates Sepsis-Associated Acute Kidney Injury via the Inhibition of Oxidative Stress and Inflammation.

Authors:  Shilin Xia; Hongli Lin; Han Liu; Zhidan Lu; Hui Wang; Songtao Fan; Nan Li
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  microRNA-23b regulates the expression of inflammatory factors in vascular endothelial cells during sepsis.

Authors:  Ming Wu; Jian-Teng Gu; Bin Yi; Zhong-Zhi Tang; Guo-Cai Tao
Journal:  Exp Ther Med       Date:  2015-01-28       Impact factor: 2.447

3.  MALAT1 modulates miR-146's protection of microvascular endothelial cells against LPS-induced NF-κB activation and inflammatory injury.

Authors:  Lin-Lin Feng; Wei-Na Xin; Xiu-Li Tian
Journal:  Innate Immun       Date:  2019-07-10       Impact factor: 2.680

4.  HIVEP1 Is a Negative Regulator of NF-κB That Inhibits Systemic Inflammation in Sepsis.

Authors:  Hisatake Matsumoto; Brendon P Scicluna; Kin Ki Jim; Fahimeh Falahi; Wanhai Qin; Berke Gürkan; Erik Malmström; Mariska T Meijer; Joe M Butler; Hina N Khan; Tsuyoshi Takagi; Shunsuke Ishii; Marcus J Schultz; Diederik van de Beek; Alex F de Vos; Cornelis van 't Veer; Tom van der Poll
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.